# | Aladdin ID | Assay Type | Description | Organism | Compounds | Reference | BAO Format | Source | |
---|---|---|---|---|---|---|---|---|---|
1. | ALA4831799 | B | Inhibition of SARS-CoV-2 RdRp transfected in human HEK293T cells cotransfected with Cov-Gluc by Gaussia luciferase reporter gene method | Severe acute respiratory syndrome coronavirus 2 | 28 | cell-based format | Scientific Literature | ||
2. | ALA4831800 | A | Cytotoxicity against human HEK293T cells assessed as reduction in cell viability incubated for 24 hrs by CCK8 assay | Homo sapiens | 28 | cell-based format | Scientific Literature | ||
3. | ALA4831801 | B | Inhibition of SARS-CoV-2 RdRp transfected in HEK293T cells cotransfected with CoV-Gluc assessed as decrease in plus and minus strand-Gluc RNA levels incubated for 24 hrs by qRT-PCR analysis | Severe acute respiratory syndrome coronavirus 2 | 6 | cell-based format | Scientific Literature | ||
4. | ALA4831802 | B | Inhibition of SARS-CoV-2 RdRp transfected in human HEK293T cells cotransfected nsp12 | Severe acute respiratory syndrome coronavirus 2 | 6 | cell-based format | Scientific Literature | ||
5. | ALA4831803 | B | Inhibition of SARS-CoV-2 RdRp transfected in human HEK293T cells cotransfected nsp12 along with nsp14 and nsp10 | Severe acute respiratory syndrome coronavirus 2 | 6 | cell-based format | Scientific Literature | ||
6. | ALA4831804 | B | Ratio of IC50 for inhibition of SARS-CoV-2 RdRp transfected in human HEK293T cells cotransfected nsp12 along with nsp14/nsp10 to IC50 for inhibition of SARS-CoV-2 RdRp transfected in human HEK293T cells cotransfected with nsp12 | Severe acute respiratory syndrome coronavirus 2 | 6 | cell-based format | Scientific Literature | ||
7. | ALA4831805 | F | Antiviral activity against HCoV-OC43 infected in HCT-8 cells assessed as reduction in viral replication treated 1 hr post infection and measured after 120 hrs post infection by MTS cell proliferation colorimetric assay | Human coronavirus OC43 | 2 | cell-based format | Scientific Literature | ||
8. | ALA4831806 | F | Antiviral activity against HCoV-NL63 infected in LLC-MK2 cells assessed as reduction in viral replication treated 1 hr post infection and measured after 120 hrs post infection by MTS cell proliferation colorimetric assay | Human coronavirus NL63 | 2 | cell-based format | Scientific Literature |